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ABSTRACT
A common feature of non-coding repeat expansion disorders is the
accumulation of RNA repeats as RNA foci in the nucleus and/or
cytoplasm of affected cells. These RNA foci can be toxic because
they sequester RNA-binding proteins, thus affecting various steps of
post-transcriptional gene regulation. However, the precise step that
is affected by C9orf72 GGGGCC (G4C2) repeat expansion, the
major genetic cause of amyotrophic lateral sclerosis (ALS), is still
poorly defined. In this work, we set out to characterise these
mechanisms by identifying proteins that bind to C9orf72 RNA.
Sequestration of some of these factors into RNA foci was observed
when a (G4C2)31 repeat was expressed in NSC34 and HeLa cells.
Most notably, (G4C2)31 repeats widely affected the distribution of
Pur-alpha and its binding partner fragile X mental retardation protein
1 (FMRP, also known as FMR1), which accumulate in intra-cytosolic
granules that are positive for stress granules markers. Accordingly,
translational repression is induced. Interestingly, this effect is
associated with a marked accumulation of poly(A) mRNAs in cell
nuclei. Thus, defective trafficking of mRNA, as a consequence of
impaired nuclear mRNA export, might affect translation efficiency
and contribute to the pathogenesis of C9orf72 ALS.
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INTRODUCTION
During the past years, the discovery of mutations in the FUS (also
known as TLS), TARDBP and C9orf72 genes led to the concept
that alterations in RNA metabolism are a major determinant of
motor neuron degeneration in amyotrophic lateral sclerosis
(ALS), similar to what occurs in other neurodegenerative
diseases (Walsh et al., 2015). Alterations in alternative splicing
have been suggested to cause the disease, but other steps of post-
transcriptional gene regulation could be equally involved (Achsel
et al., 2013). C9orf72, the major genetic determinant of ALS
(DeJesus-Hernandez et al., 2011; Renton et al., 2011), is a prime
example of how little we understand: analogies with other repeat
expansion diseases suggest three possible scenarios that could play
a role in the pathogenesis of ALS linked to C9orf72 GGGGCC
(G4C2) repeat expansions. One stems from reduced expression of
the C9orf72 protein, the others from the accumulation of repeat-
containing RNAs that might either trap specific RNA-binding
proteins, thereby disrupting RNA processing, or undergo an
unconventional mode of translation [repeat-associated non-ATG
(RAN) translation], which results in the accumulation of toxic poly-
dipeptides (Gendron et al., 2014). However, whether accumulation
of toxic RNA species and/or haploinsufficiency of C9orf72 is the
leading pathological mechanism in ALS is unknown.
A common feature of non-coding repeat expansion disorders is
the accumulation of RNA repeats as RNA foci in the nucleus and/
or cytoplasm of affected cells. These foci are able to sequester
RNA-binding proteins, which can affect various steps of post-
transcriptional gene regulation, such as alternative mRNA splicing,
translational regulation, mRNA transport or mRNA decay (La
Spada and Taylor, 2010). In samples from C9orf72 patients as well
as patient-derived induced pluripotent stem cells (iPSCs), RNA
foci containing the sense as well the antisense RNA repeat
sequence are likewise detected (DeJesus-Hernandez et al., 2011;
Donnelly et al., 2013), indicating that the sequestration of RNA-
binding proteins and hence a dysregulation in one of the steps of
mRNA metabolism might well play a role in ALS. The precise
step that is affected, however, remains ill defined, and our
understanding of C9orf72 toxicity thus is still elusive. As a first
hint to characterize these mechanisms, we used a biotinylated RNA
containing (G4C2)31 repeats to identify proteins that bind to
C9orf72 RNA. Based on the ability of (G4C2)31 repeats to bind
proteins involved in translational control, we analyzed whether
protein translation could be affected in cultured cells expressing the
same repeats. Indeed, we observed that the expression of (G4C2)31
is able to activate a stress response that leads to a general reduction
of translation. In these conditions, C9orf72 repeats strikingly
induce an abnormal nuclear accumulation of poly-adenylated
mRNAs. Thus, nuclear retention of mRNAs, as a consequence of
the ability of the C9orf72 repeats to impair nuclear mRNA export,
might contribute to ALS pathogenesis.
RESULTS
(G4C2)31 repeats aggregate in RNA foci in mouse
motorneuronal NSC34 cells
In order to produce GGGGCC repeat expansions with selected
lengths, we synthesized two complementary oligonucleotides
containing three G4C2 repeats and overhangs to allow
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head-to-tail ligation. Annealed oligonucleotides were ligated,
fractionated on an agarose gel, and various repeat lengths were
cloned in an expression vector (pcDNA5/FRT/TO). With this
approach, we were able to select a repeat of 31 uninterrupted
GGGGCC units (G4C2)31 that was transiently transfected into
mouse motoneuronal-like NSC34 cells, and compared to a plasmid
containing ten repeats (G4C2)10. Expression of (G4C2)31 was
sufficient to induce the appearance of intense intranuclear RNA
foci (Fig. 1A), as stained by fluorescence in situ hybridization
(FISH) analysis using a Cy3-conjugated (C4G2)4 RNA probe.
Under the same conditions, ten repeats, whose expression
levels are comparable to the (G4C2)31 (Fig. 1B), did not form
intracellular foci (Fig. 1A). A cytoplasmic staining was also
evident in cells transfected with the longer repeat, with cytoplasmic
foci occasionally appearing (Fig. 1A). As expected from the nature
of the probe target, treatment with RNase, but not DNase,
completely abolished the signal (supplementary material Fig.
S1). Transfection of NSC34 cells with a plasmid bearing 270
repeats of the trimer TTC, that is expressed to similar levels as
(G4C2) 10 and 31 (Fig. 1B), did not induce the appearance of Cy3-
(C4G2)4 positive signals (Fig. 1A). Similarly, a CUG RNA
expanded repeat, that is known to form RNA foci, is not
recognised by the Cy3-(C4G2)4 probe (supplementary material
Fig. S1), further indicating the specificity of the experimental
conditions used. The same (G4C2)31 repeats were inserted
upstream of a GFP coding sequence and transfected in NSC34
cells. As shown in Fig. 1C,D,,30% of GFP-positive cells showed
foci formation after 48 h of transfection, whereas in the same
Fig. 1. (G4C2)31 repeats form intracellular RNA foci. (A) NSC34 cells were transiently transfected with plasmids coding for 31 (upper panel) or ten (middle
panel) G4C2 repeats, and for 270 TTC repeats (lower panel). After 48 h, cells were subjected to FISH analysis with a C4G2 RNA probe conjugated to Cy3 (red).
Nuclei were stained with DAPI (blue). Scale bar: 10 mM. (B) Cells were transfected as in A. After 48 h, expression of repeat-containing RNAs was analyzed
by RT-qPCR. Shown are the levels relative to the cells expressing the (G4C2)10 repeat. RNAs from untransfected cells (NT), as well as input RNAs from
(G4C2)31-transfected cells (RNA input) were used as the negative control. Mean6s.d. is shown (n53). (C) NSC34 cells were transfected with plasmids coding
for (G4C2)31 or (G4C2)10 repeats and GFP. After 48 h, cells were subjected to FISH analysis with a Cy3–C4G2 RNA probe. Nuclei were stained with DAPI
(blue). Scale bar: 10 mm. (D) The percentage of GFP-expressing cells that show RNA foci was scored (mean6s.d. from n53 independent experiments).
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conditions of GFP expression, no foci are detectable in cells
transfected with a GFP-(G4C2)10 plasmid. Therefore, the
accumulation into nuclear foci is a prevalent feature of (G4C2)31
RNA repeat expression. Further, overexpression of 31 repeats is
sufficient to reproduce a key pathological phenotype that
characterizes C9orf72 patients carrying longer expansions.
Repeat-binding proteins are involved in pre-mRNA splicing
and mRNA translation
To get insights into the mechanisms whereby C9orf72 might
induce cell toxicity, we used an in-vitro-transcribed biotinylated
RNA containing the (G4C2)31 repeats to affinity purify proteins
able to bind it. The major repeat-binding proteins frommouse brain
and spinal cord extracts were visualised by Coomassie staining
of SDS-polyacrylamide gels, excised and identified by mass
spectrometry (supplementary material Table S1; Fig. S2). Among
the interactors, we found different factors involved in post-
transcriptional gene regulation. Indeed, G4C2-repeat-binding
proteins are enriched in members of the heterogeneous nuclear
ribonucleoprotein (hnRNP) family (hnRNP H, hnRNP U, hnRNP
Q), which are known key regulators of alternative splicing (Chen
and Manley, 2009). However, translational regulators also bind
(G4C2)31: these include initiation and elongation factors (EF1a,
eIF2a, eIF2b and eIF2c), and also Pur-alpha (Pura), Pur-beta and
other translation regulatory proteins [ILF2, ILF3 and RAX (also
known as PRKRA or PACT)]. To validate the mass spectrometry
data, a subset of the identified proteins was analyzed by western
blotting on proteins pulled down by the (G4C2)31 RNA repeat from
mouse brain and spinal cord (data not shown), as well as mouse
(NSC34) and human (SH-SY5Y) cultured neuronal cells. As
shown in Fig. 2A, all the proteins tested could be detected, with
different binding affinity depending on the stringency conditions.
When the same proteins were analyzed in extracts pulled down
with a biotinylated (TTC)270 RNA repeat, only hnRNP H, eIF2a,
eIF2b and RAX displayed a significant specificity for the (G4C2)31
RNA repeat, whereas the other proteins tested precipitate to the
same or even higher degrees (Fig. 2B,C). By contrast, none of the
proteins tested was detected in control precipitates. Overall, these
data suggest that G4C2 binding to Pura, hnRNP U, ILF2 and ILF3
might not be required for C9orf72 toxicity. Based on their
described ability to bind the C9orf72 repeats (Lee et al., 2013; Mori
et al., 2013; Reddy et al., 2013), we also checked for the presence of
FUS, TDP43, hnRNPA2/B1 and SRSF1 as repeat-binding partners
(Fig. 2D). Again, binding of these proteins to (G4C2)31 was
observed. Importantly,MBNL1, whose sequestration by CUGRNA
repeats has a prominent role in DM1 pathogenesis, was in no
Fig. 2. (G4C2)31 repeat RNA binds factors involved in pre-mRNA splicing and mRNA translation. (A) Lysates from NSC34 cells were incubated at the
indicated NaCl concentrations with a biotinylated (G4C2)31 repeat. Pulled-down proteins were then analyzed by western blotting with the indicated antibodies.
0.2% and 2% of inputs were analyzed as a loading control. The two different ILF3 isoforms of 90 and 110 kDa are bound. (B) Lysates from NSC34 cells were
incubated at 200 mM NaCl concentration in the absence (no RNA) or in the presence of biotinylated (G4C2)31 or (TTC)270 repeats, and analyzed by
western blotting as indicated. 2% of inputs were analyzed as a loading control. (C) Quantification of the precipitation efficiency shown in B. The amounts of the
indicated proteins are expressed as mean6s.d. of arbitrary densitometric units (AU) relative to (G4C2)31 precipitates. *P,0.05, **P,0.01 compared with relative
controls (n53). (D) Lysates from NSC34 or SH-SY5Y cells were incubated with biotinylated (G4C2)31 RNA and pulled-down proteins were analyzed by western
blotting with indicated antibodies.
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instance precipitated by C9orf72 repeats (Fig. 2A), indicating that
(G4C2)31 repeat is selective for the binding to a subset of RNA
binding proteins.
(G4C2)31 repeats sequester RBPs into RNA foci and disturb
the intracellular localization of Pura and FMRP
Sequestration of (G4C2)31-binding proteins into RNA foci has
been suggested to cause a decreased availability of those proteins,
thus affecting their function and eventually leading to cell death.
We therefore looked for the presence of the above identified
proteins in RNA foci formed by (G4C2)31 repeats in NSC34 cells.
Among the proteins tested, hnRNP H, eIF2a, FUS and ILF3
showed a clear colocalization with RNA foci (Fig. 3A), whereas
the other proteins did not significantly colocalize (not shown). To
assess whether the accumulation of (G4C2)31-binding proteins
into RNA foci could be dependent on the cellular context, we also
performed a similar analysis in human HeLa cells, obtaining
comparable results (Fig. 3B). In both cellular types, however, the
number of cells where RNA foci colocalized with those proteins
was extremely low (less than 3%). Thus, although the presence of
the proteins into RNA foci indicates that their interaction with
G4C2 repeats also occurs in vivo, these results suggest that the
formation of RNA foci by the (G4C2)31 repeats does not normally
affect the overall subcellular distribution of the partners analyzed.
Pura represents a striking exception. Indeed, whereas this protein
only occasionally showed a clear colocalization with RNA foci, in
almost all the cells displaying (G4C2)31 RNA foci formation, the
intracellular distribution of Pura was profoundly affected, with an
evenly diffused localization in the cytosol of untransfected cells,
but with it coalescing into cytosolic and nuclear granules in cells
with RNA foci. A similar result was obtained with FMRP, a known
binding partner of Pura (Fig. 4A). In cells transfected with
(G4C2)31 repeats, FMRP accumulated into cytosolic and, to a
lesser extent, nuclear granules. The same pattern of Pura and
FMRP delocalization was induced by (G4C2)31 expression in
HeLa cells (Fig. 4B). Interestingly, FMRP is also pulled down by
(G4C2)31 RNA (supplementary material Fig. S3), but differently
from other partners analyzed, this interaction was completely lost
when the NaCl concentration was raised to 300 mM, suggesting
that the binding of FMRP is not direct, and might be mediated by
Pura itself. This conclusion is further supported by the observation
that Pura and FMRP colocalized in cells expressing the (G4C2)31
repeats, but not the (G4C2)10 nor the (TTC)270 repeats
(supplementary material Fig. S3).
(G4C2)31 repeats induce translational arrest
The ability of (G4C2)31 repeats to bind eIF2a, a central controller
of protein translation, as well as the effects of repeat expression
on the subcellular distribution of Pura and FMRP, whose
functions in protein translation are well documented (Bagni and
Oostra, 2013; White et al., 2009), prompted us to analyze whether
(G4C2)31 is able to affect protein translation. HeLa cells, a well
established model to study stress response, were therefore
transiently transfected with (G4C2)31 repeats, and the presence
of stress granules, where non-functional translation initiation
complexes accumulate in response to stress, was analyzed.
Indeed, stress granules were formed in the vast majority of cells
expressing the (G4C2)31 repeats, but not in cells expressing
similar amounts of (G4C2)10 or (TTC)270 RNAs, as measured by
the presence of intra-cytoplasmic granules that are positive for
TIA-1-related protein (TIAR, also known as TIAL1), a known
stress granule marker (Fig. 5A–D). Importantly, Pura granules
(Fig. 5A), as well as FMRP granules (data not shown), are
positive for TIAR. Thus, C9orf72 repeat is able to activate in cells
a stress response that induces stress granules formation.
Phosphorylation of eIF2a (P-eIF2a) is the leading mechanism
that causes the formation of non-functional translation initiation
complexes and their accumulation into stress granules, and the
phosphorylation status of eIF2a is thus an indication of translational
inhibition (Spriggs et al., 2010). P-eIF2a levels were therefore
monitored with a phospho-specific antibody in HeLa cells
transfected with (G4C2)31 repeats. As shown in Fig. 6A, no
significant increase in eIF2a phosphorylation was detectable in
cells expressing the (G4C2)31 repeats, compared to cells expressing
shorter expansions (ten repeats) or to mock-transfected cells. By
contrast, in the same cells treated with thapsigargin, a well-known
inducer of ER stress mediated through the activation of PERK
kinase (also known as EIF2AK3), a significant increase in P-eIF2a
was detected. Thus, eIF2a phosphorylation does not seem to be a
crucial step in the stress response induced by (G4C2)31.
To check whether this response is nonetheless sufficient to
cause translation inhibition, cells were analyzed for their ability
to incorporate puromycin into nascent polypeptides as a measure
of the rate of mRNA translation (Schmidt et al., 2009). Both
western blot analysis (Fig. 6B) and immunofluorescence staining
(Fig. 6C,D) of transfected cells clearly shows that puromycin
incorporation is considerably decreased in HeLa and NSC34 cells
expressing (G4C2)31, but not (G4C2)10 nor (TTC)270 repeats. As
expected, pre-treating of cells with cycloheximide completely
abolishes puromycin incorporation.
mRNAs accumulate in nuclei of (G4C2)31-expressing cells
Previous data indicate that a significant inhibition of global
mRNA translation is achieved in cells expressing C9orf72 repeats
independently from the phosphorylation of eIF2a, thus implying
alternative mechanisms whereby translational inhibition is carried
out by G4C2 expansions. One obvious possibility is that G4C2
RNA repeats might cause a failure in mRNA export from nuclei,
eventually leading to the accumulation of poly(A) RNAs into
them. To investigate this possibility, cells were left untransfected
or were transfected with (G4C2)10 or (G4C2)31 repeats, and
poly(A) RNAs were visualized by oligo(dT) FISH. To exclude
the possibility that the probe might recognize the poly(A) tail of
the overexpressed (G4C2)31 RNAs that indeed accumulate in
nuclei, the repeat sequence was cloned under the control of an
RNA polymerase III promoter, and a small poly(T) stretch was
inserted immediately after the repeat sequence as a transcription
termination signal. As shown in Fig. 7A–C, an enhancement of
the poly(A) RNA signal in the nucleus was clearly detectable in
cells displaying G4C2 RNA foci, compared to untransfected or
(G4C2)10-transfected cells (supplementary material Fig. S4A).
Importantly, poly(A) RNAs accumulate as nuclear dots that only
partially colocalize with (G4C2)31 RNA foci, thus excluding a
direct sequestration of poly(A) mRNAs by the repeat sequence.
When stress granule formation was induced by sodium arsenite,
poly(A) mRNAs aggregated in TIAR-positive stress granules, as
expected (Fig. 7D). In this condition, however, no mRNA
accumulation in cell nuclei was observed, suggesting that
nuclear mRNA retention by the (G4C2)31 repeat is not a mere
consequence of the formation of cytoplasmic stress granules. This
conclusion is further supported by the subcellular distribution of
the cytoplasmic poly(A)-binding protein (PABPc, also known as
PABPC1) in cells expressing (G4C2)31 repeats. It has been
recently shown, in fact, that nuclear accumulation of poly(A)
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RNAs is associated with relocalization of PABPc in cell nuclei.
PABPc has an established, fundamental role in cytosolic mRNA
translation and stability (Burgess et al., 2011; Kumar and
Glaunsinger, 2010) and it is known to localize into stress
granules upon stress (Kedersha et al., 2000). We therefore
analyzed PABPc distribution in cells expressing the (G4C2)31
repeats. Immunofluorescence staining of cells shows that, as
expected, PABPc has a prevalent cytoplasmic steady-state
localization in a majority of untransfected cells. However, in a
substantial fraction of (G4C2)31-transfected cells (1062%,6s.d.),
an evident nuclear PABPc signal could be seen (Fig. 8A), whereas
the cytosolic distribution of PABPc in cells expressing (G4C2)10 or
Fig. 3. (G4C2)31 repeats sequester RNA-binding proteins
into RNA foci. (A) NSC34 cells were transiently transfected
with a plasmid expressing (G4C2)31 repeats and analyzed
after 48 h by RNA FISH using a Cy3–(C4G2)4 probe (red)
and by immunofluorescence staining (green) with antibodies
recognizing different RNA-repeat-binding proteins (eIF2a,
FUS, hnRNP H and ILF3). (B) HeLa cells were transiently
transfected with a plasmid expressing (G4C2)31 repeats and
analyzed after 24 h as in A. The overlay of the two colors is
shown. Nuclei were stained with DAPI. Scale bars: 10 mm.
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(TTC)270 was unaffected (Fig. 8B) A similar result was obtained
when cells were transfected with repeat-GFP plasmids
(supplementary material Fig. S4B), or when nuclear and
cytoplasmic fractions of cells were analyzed by western blotting
(Fig. 8C). Interestingly, a considerable number of transfected cells
displayed a clear accumulation of PABPc into RNA foci (Fig. 8A),
and PABPc is pulled down by (G4C2)31 RNA (Fig. 8D), but not by
(TTC)270 RNA. Importantly, PABPc only rarely colocalized with
the Pura-containing cytosolic stress granules that were induced by
(G4C2)31 repeats, which is different from what is observed in cells
treated with arsenite, where PABPc and Pura fully colocalize
(Fig. 8E). Thus, a nuclear relocalization of PABPc is specifically
induced by (G4C2)31, and this is associated with the nuclear
retention of poly(A) mRNAs.
DISCUSSION
The presence of C9orf72 RNA inclusions in tissues from ALS or
frontotemporal dementia (FTD) patients, as well as the formation
of similar inclusions in cellular systems expressing the repeats,
including iPSC-derived motor neurons, provided an early support
for the hypothesis that sequestration of RNA-binding proteins by
C9orf72 repeat might have a role in disease pathogenesis (Walsh
et al., 2015). Evidence from histopathological analysis of RNA
foci in tissues from ALS and/or FTD patients has shown a
positive correlation between the number of repeat-containing foci
and disease presentation or severity (Cooper-Knock et al., 2014;
Mizielinska et al., 2013), further indicating that accumulation of
C9orf72-derived G4C2 RNA repeats are primary involved in
the neurodegenerative process. However, the nature of the
mechanisms affected by this accumulation is still unknown. To
get insights into this process, we have characterized the major
binding partners of a (G4C2)31 repeat. Our analysis showed that a
substantial number of binding partners are RNA regulatory
factors, as expected by the nature of the repeat sequence and in
line with previous analyses showing that splicing and translation
regulatory factors are binding partners of C9orf72 (Cooper-
Knock et al., 2014; Donnelly et al., 2013; Haeusler et al., 2014;
Mori et al., 2013; Xu et al., 2013). In our study, translational
regulators are particularly represented: these include initiation
and elongation factors (EF1a, eIF2a, eIF2b, eIF2c), but also
Pura, Pur-beta and other translation regulatory proteins (ILF2,
ILF3 and RAX). Trying to figure out which of these interactors
might be more directly involved in C9orf72 repeat toxicity, we
therefore reasoned that the amount of sequestration into RNA foci
might represent a discriminating factor. Surprisingly, at least
among the binding partners tested, only a limited number were
found in association with the RNA foci that are formed in
cultured cells by the expression of 31 repeats, and even in these
Fig. 4. (G4C2)31 repeats affect
Pura and FMRP localization in
NSC34 and HeLa cells. (A) NSC34
cells were transiently transfected with
a (G4C2)31-expressing plasmid and
analyzed after 48 h by RNA FISH
using a (C4G2)4 probe conjugated
to Cy3 (red) and by
immunofluorescence staining (green)
with anti-Pura (upper panels) and
anti-FMRP (lower panels) antibodies.
In untransfected cells, Pura and
FMRP have a diffuse cytosolic
localization, whereas in cells that
express (G4C2)31 repeats both
proteins accumulate into cytosolic
and nuclear granules. The white
arrowhead points to a nuclear
granule where Pura and G4C2
repeat colocalise. Higher
magnifications of the areas
highlighted by the box are shown
together with DAPI staining. (B) HeLa
cells were transiently transfected with
(G4C2)31 repeats and analyzed after
24 h by RNA FISH as in A. Scale
bars: 20 mm.
RESEARCH ARTICLE Journal of Cell Science (2015) 128, 1787–1799 doi:10.1242/jcs.165332
1792
cases, the amount of colocalization was really low
(supplementary material Table S2). Clearly, we cannot exclude
that the length of the repeats, as well as the duration of the
process, can influence the appearance of such a phenotype.
Indeed, observations in brain tissues from C9orf72 ALS and FTD
patients, who usually bear longer expansions that accumulate
over a large period of time, show that a substantial number of
G4C2 RNA foci colocalize with hnRNP H (Lee et al., 2013), and
to a lower, but still significant extent, with SRSF2 and ALYREF
(Cooper-Knock et al., 2014). This argues in favor of such a
conclusion. However, numerous inconsistencies emerge from
studies where tissues from ALS and/or FTD patients have been
surveyed for proteins that co-aggregate with RNA foci (Stepto
et al., 2014), suggesting that a dynamic interaction between
accumulated RNA repeats, either aggregated in foci or not, and
selected targets, rather than an irreversible sequestration, might
better describe the pathogenic mechanism (Cooper-Knock et al.,
2014). Our results support this idea and suggest that RNA repeats
might affect the proper localization and/or function of a
distinguished set of RNA-binding proteins independently from
Fig. 5. (G4C2)31 repeats induce stress granules formation. (A) HeLa cells were transiently transfected with a plasmid expressing (G4C2)31 repeats. After
24 h, RNA foci were visualized by FISH analysis with a Cy3–(C4G2)4 probe conjugated to Cy3 (red) together with immunofluorescence staining with anti-TIAR
(green) and anti-Pura (blue) antibodies. The overlay of the three colors (merge), and a higher magnification of the area highlighted by the box are shown.
In cells expressing (G4C2)31 repeats, Pura accumulates in TIAR-positive stress granules (white arrows). Nuclei were stained with DAPI (white). Scale bar:
20 mm. (B) HeLa cells were transfected with (G4C2)10 or (TTC)270 plasmids as in A. After 24 h, immunofluorescence staining with antibodies anti-TIAR (green)
and anti-Pura (blue) was performed, together with DAPI staining (white). Images are presented at the same magnification as in A. (C) Cells were transfected as
in A with the indicated plasmids. After 24 h, expression of repeat-containing RNAs was analyzed by qRT-PCR. Shown are the levels relative to the cells
expressing the (G4C2)10 repeat. RNAs from untransfected cells, as well as input RNAs from (G4C2)31-transfected cells were used as negative control.
Mean6s.d. is shown (n53). (D) Cells transfected with the indicated plasmids and presenting stress granules were scored and plotted according to the presence
(w/, with foci, red) or absence (w/o, without foci, blue) of RNA foci. Values are reported as mean percentage 6 s.d. from three independent experiments.
*P,0.01 compared with relative controls.
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their sequestration into nuclear foci, a conclusion that is also
consistent with the presence of RNA repeats in the cytosol of cells,
where they do not necessarily form RNA inclusions containing
co-aggregated proteins. Among these RNA binding proteins,
hnRNPH, eIF2a, eIF2b and RAX might represent relevant
targets of C9orf72 expansion, as their interaction with the
(G4C2)31 repeat proved to be specific when compared to the
binding to an unrelated TTC repeat expansion that is not sufficient
to induce cellular phenotypes when expressed in NSC34 or HeLa
cells. However, Pura, which has been implicated in G4C2-induced
neurodegeneration (Xu et al., 2013), binds to the two repeats with
the same affinity. Thus, the nature of the particular RNA process
affected by C9orf72 could not be easily anticipated by a
colocalization analysis or simply argued by the types of binding
partners found to be associated to the repeats, and a functional
analysis is needed to draw any conclusion.
Functionally, the most striking effect of C9orf72 expression is
the induction of translational arrest. Indeed, in this study we show
for the first time that stress granules are formed in cells where
C9orf72 RNA repeats accumulate into nuclear foci, and this
phenotype well correlates with a strong reduction in the rate of
global translation. Mounting evidence indicates that stress-granule-
associated translational repression might have a role in ALS
pathogenesis. FUS and TAR DNA-binding protein 43 (TDP-43,
also known as TARDBP), two major ALS factors, are known to
accumulate into stress granules upon stress, and ALS-linked
mutations clearly affect stress granule formation, eventually
impairing a neuroprotective effect of this process or generating a
persistent presence of stress that might be harmful to neurons
(Bentmann et al., 2013). Moreover, stress granule genes are potent
modifiers of TDP-43 toxicity in Drosophila, and decreased
translational repression has a protective effect (Kim et al., 2014).
Thus, our observations extend this scenario to C9orf72-mediated
ALS. In the cell lines tested, however, phosphorylation of eIF2a,
which results in decreased production of the ternary complex
needed for translation initiation, does not seem the major
mechanism whereby translational inhibition is achieved. Based
on the interaction between the G4C2 RNA repeat and eIF2a, which
we found occurred both in vitro and in cell culture, it could be
assumed that eIF2a function might be impaired independently
from its phosphorylation, and that this might in turn be responsible
for the observed assembly of stress granules. Indeed, stress
Fig. 6. (G4C2)31 repeats induce eIF2a-
phosphorylation-independent translational
arrest. (A) Untransfected HeLa cells or cells
transiently transfected with mock, (G4C2)10 or
(G4C2)31 plasmids, were grown in the absence
or presence of the PERK inhibitor
GSK2606414 (PI), at the indicated
concentrations. After 24 h, where specified,
cells were treated with 5 mM thapsigargin (TG)
for 2 h, and cell lysates were analyzed by
western blotting with antibodies that specifically
recognize phosphorylated eIF2a (P-eIF2a) or
total eIF2a. The lower panel shows the
quantification of the bands, presented as the
ratio of the P-eIF2a over the total eIF2a and
expressed in arbitrary units (AU), and reported
as mean6s.d.; n54. *P,0.01 compared with
relative controls. (B) HeLa cells were left
untransfected (NT), or were transiently
transfected with an empty vector (mock), or
vectors containing (G4C2)10, (G4C2)31 and
(TTC)270 repeats. After 24 h, cells were treated
with 10 mg/ml puromycin for 10 min and cell
lysates were analyzed by western blotting with
an antibody against puromycin. b-actin was
analyzed as a standard for equal protein
loading. The puromycin incorporation rate in
untransfected cells pre-treated with 1 mM
cycloheximide (CHX) for 10 min was also
analyzed. The lower panel shows the
quantification of the bands, expressed in
arbitrary units (AU), relative to untransfected
cells, and reported as mean6s.d.; n53.
*P,0.01 compared with relative controls.
(C) HeLa cells were transiently transfected with
a plasmid expressing (G4C2)31 repeats. After
24 h, cells were treated with puromycin, and
then analyzed by Cy3–(C4G2)4 RNA FISH
(red) and by immunofluorescence staining with
an anti-puromycin antibody (green). Nuclei
were stained with DAPI (white). (D) NSC34
cells were transiently transfected with (G4C2)31
repeats, and analyzed as in (C) after 48 h.
Scale bars: 20 mm.
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granules are formed when the availability of eIF2a, as well as other
translational factors, is decreased by small interfering RNA
(siRNA) (Mokas et al., 2009), a situation that might be
mimicked by RNA repeat sequestration. As an alternative,
decreased mRNA export from cell nuclei, as suggested by the
clear accumulation of poly(A) RNA in the nuclei of cells
expressing (G4C2)31 repeats, might explain, at least in part, this
phenomenon. Which is the factor that provokes nuclear
accumulation of poly(A) mRNAs in the presence of G4C2 RNA
expression? One interesting possibility is that nuclear
accumulation of PABPc might be the principal driver of mRNA
nuclear retention. The cytoplasmic form of PABP (PABPc) is a
nucleo-cytosol shuttling protein with a steady-state expression in
the cytoplasm, where it enhances translational efficiency by
bridging the poly(A) tail to the cap-binding complex through the
eIF4G protein (Smith et al., 2014). Further, PABPc is found into
stress granules upon cell stress (Kedersha et al., 2000). However,
PABPc is also known to relocalize in the nuclei of cells when
Fig. 7. mRNAs accumulate in the nuclei of cells expressing (G4C2)31 repeats. (A) NSC34 cells were transiently transfected with a plasmid
(pSUPER.retro.puro) expressing (G4C2)31 repeats and analyzed after 48 h by RNA FISH using a (C4G2)4 probe conjugated to Cy3 (red) and an oligo(dT) probe
labeled with Cy5 (blue). Scale bar: 20 mm. (B) HeLa cells were transfected and analyzed after 24 h as in (A). In cells expressing (G4C2)31 repeats mRNAs
accumulate as nuclear dots, that partially colocalize with RNA foci. A higher magnification of the areas highlighted in the inset is shown, together with DAPI
staining (grey). Scale bar: 10 mm. (C) Cells presenting RNA foci were scored and plotted according to the presence of mRNA accumulated in nuclei. At least 50
cells for each condition were counted. Values are reported as the mean percentage 6 s.d. from three independent experiments. (D) HeLa cells were treated with
1 mM NaAs for 30 min and analyzed by RNA FISH using an oligo(dT) labeled with Cy5 (blue). Cells were also stained with an anti-TIAR antibody (green). A
higher magnification of the area highlighted in the inset is shown, together with DAPI staining (white). Images in D are presented at the same magnification as
in B.
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accumulation of mRNAs in cell nuclei as well as translational
inhibition are induced by a subset of viral proteins (Smith and
Gray, 2010). Interestingly, the obligatory expression of a nuclear
targeted PABPc protein is sufficient to cause a dramatic increase in
poly(A) mRNAs in cell nuclei (Kumar and Glaunsinger, 2010).
Thus, PABPc localization appears to be an important determinant
of mRNA fate. We observed in this work that C9orf72 G4C2
repeats bind to PABPc, sequester it into nuclear foci and induce its
nuclear accumulation. For these reasons, it is tempting to speculate
that nuclear retention of PABPc by G4C2 might represent a crucial
point in the pathogenic cascade that originates from RNA repeat
expression, and could be in accordance with the evidence showing
Fig. 8. (G4C2)31 repeats induce the re-localization of cytoplasmic PABP in cell nuclei. (A) HeLa cells were transiently transfected with (G4C2)31 repeats
and analyzed after 24 h by RNA FISH (red) and by immunofluorescence staining with anti-PABPc (green) and anti-Pura (blue) antibodies. Nuclei were stained
with DAPI (white). Scale bar: 20 mm. (B) HeLa cells were transfected with (G4C2)10 or (TTC)270 plasmids and stained after 24 h with anti-PABPc (green) and
anti-Pura (blue) antibodies (C) HeLa cells were transiently transfected with (G4C2)31 repeats or left untransfected (NT). After 24 h, nuclear and cytosolic
fractions from cells were isolated and analyzed by western blotting using an anti-PABPc antibody. Pura and the nuclear protein lamin B were also examined as
standards for equal protein loading in the two fractions. (D) Lysates from HeLa cells were incubated with NaCl (200 mM) in the absence (no RNA) or in the
presence of biotinylated (G4C2)31 or (TTC)270 repeats, and analyzed by western blotting with an anti-PABPc antibody. 0.5% input was analyzed as a loading
control. (E) HeLa cells were treated with 1 mM NaAs for 30 min and analyzed by immunofluorescence staining with anti-PABPc (green) and anti-Pura (blue)
antibodies. A higher magnification of the highlighted area is shown. Images in B and E are presented at the same magnification as in A.
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that PABPc is found in TDP43-containing inclusions in ALS
patients (McGurk et al., 2014). This suggests that PABPc could be
an important factor in the pathology of ALS. However, nuclear
accumulation of PABPc might be one required component of the
observed phenomena, but other factors might be necessary as well.
Among the C9orf72-binding partners, the mRNA export adaptor
ALYREF has been recently described to be highly represented in
RNA foci in cerebellar granule cells and in motor neurons from
C9orf72 ALS patients (Cooper-Knock et al., 2014). This
observation suggests that accumulated RNA repeats might
interfere with the proper delivery of mRNAs from nuclei to
cytosol, eventually affecting gene expression. As a matter of fact,
Fragile X premutated rCGG repeats, which are responsible for
Fragile X-associate tremor/ataxia syndrome (FXTAS), induce
nuclear accumulation of mRNAs, including mRNAs involved in
stress response, in a Drosophila model (Qurashi et al., 2011).
Notably, this process is mediated by the interaction of the
Drosophila homologue of the p68 RNA helicase, Rm62, with
Pura, whose localization is profoundly affected by C9orf72
expression, as shown in this work, and has been suggested to
play a pivotal role in C9orf72-mediated neurodegeneration in
Drosophila (Xu et al., 2013). Whether mRNA export defects
represent a disease-relevant mechanism in ALS cases caused by
C9orf72, and how this process might influence the formation of
RAN peptides from C9orf72 translation, an important contributing
factor to C9orf72 toxicity, obviously needs further investigation.
However, motor neurons seem to be particularly sensitive to
alterations in this process, as mutations in the human GLE1 gene,
that has a central function in nuclear mRNA export, are responsible
for the autosomal recessive lethal congenital contracture
syndrome-1 (LCCS1), a disease characterized by lack of anterior
horn motor neurons and severe atrophy of the ventral spinal cord
(Folkmann et al., 2013).
In summary, we have shown here that accumulation of C9orf72
RNA repeats inside cells is associated with the formation of
stress granules, a marked translational repression and a striking
accumulation of poly(A) mRNAs in cell nuclei. Our data
therefore extend to C9orf72-dependent ALS the emerging
concept that stress-granule-associated translational repression
has a prominent role in neurodegenerative disorders, including
ALS, and raise the intriguing possibility that the hexanucleotide
expansion in C9orf72 might interfere with the cellular trafficking
of poly(A) RNAs, thus increasing our current understanding
of the molecular mechanisms underlying the pathogenesis of
familial ALS.
MATERIALS AND METHODS
DNA synthesis and plasmid construction
CC(GGGGCC)2GGGG and CCGG(CCCCGG)2CC DNA fragments were
synthesized with a 59 phosphate (Sigma). Complementary DNA strands
were incubated at 95 C˚ for 5 min in the presence of 100 mM potassium
acetate, 2 mM magnesium acetate and 30 mM Hepes-KOH pH 7.4, then
slowly cooled to 65 C˚. After 30 min, the reaction was further cooled to
4 C˚. 3 mg of annealed oligonucleotides were ligated at room temperature
for 24 h by T4 DNA ligase (Promega) and then separated on 1% agarose
gel. DNA fragments with different lengths were extracted and cloned into
the XmaI site of pPCR-Script AmpSK(+) vector (Agilent Technologies).
Plasmids containing ten and 31 repeats were obtained and verified by
automated sequencing. The hexanucleotide repeats were subcloned into
the EcoRV/NotI sites of pcDNA5/FRT/TO expression vector (Invitrogen)
and into the BglII/HindIII sites of pEGFP vector (Clontech). For
subcellular distribution of poly(A) mRNAs, the repeats were inserted into
NotI/BglII sites of pSUPER.retro.puro (Oligoengine), which contains an
RNA polymerase III promoter and was previously modified for the
presence of a transcription termination (six thymidine residues
immediately downstream the cloning site).
For (TTC)270 cloning, a 1300-bp DNA fragment containing 270
Friedreich’s-ataxia-associated repeats of a GAA sequence was PCR-
amplified from genomic DNA from a human carrier and cloned into
pGEM-T Easy Vector (Promega). NotI fragments were then inserted into
pcDNA5/FRT/TO vector. Sequence orientation was controlled by
restriction analysis of each vector and verified by automated sequencing,
and the reverse orientation containing a 59-(TTC)270-39 repeat was used for
the experiments.
Cell culture and transfection
Mouse motor neuron-like NSC34 cells were grown in Dulbecco’s modified
Eagle’s medium (DMEM) with F12 (Invitrogen) supplemented with 10%
fetal bovine serum (tetracycline free, Lonza) at 37 C˚ in an atmosphere of
5% CO2 in air. Human neuroblastoma SH-SY5Y cells and cervical
carcinoma HeLa cells were grown in DMEM (Invitrogen) supplemented
with 10% fetal bovine serum (Invitrogen) at 37 C˚ in an atmosphere of 5%
CO2 in air. For transient expression of hexanucleotide repeats, NSC34 and
HeLa cells were transfected with pcDNA5-(G4C2)10, pcDNA5-(G4C2)31
and pcDNA5-(TTC)270 using Lipofectamine Plus reagent (Invitrogen)
according to the manufacturer’s instruction.
qRT-PCR analysis
For quantitative real-time PCR (qRT-PCR), RNAs were isolated using
TRIzol (Invitrogen) and treated with DNase. RNAs were quantified and
reverse-transcribed with random primers according to an ImProm II
reverse transcriptase kit (Promega). qRT-PCR was performed with
LightCycler 480 SYBR Green I Master Mix (Roche). A 113-bp sequence
of pcDNA5/FRT/TO upstream of the repeat cloning sites was amplified
using the following primers: forward, 59-CGCAAATGGGCGGTA-
GGCGTG-39; reverse, 59-CACTAAACGAGCTCGTCGACG-39. Actin
was also measured as a housekeeping gene.
RNA transcription in vitro and pulldown assay
pPCR-Script-(G4C2)31 and pGEM-(TTC)270 vectors were linearized with
SacI or SalI, respectively, and used as a template for in vitro RNA
transcription, that was performed with RNAMaxx High Yield
Transcription Kit (Agilent Technologies) in the absence or presence of
biotin-14-CTP (Invitrogen) in a one-to-one ratio of normal to modified
cytosine, following the manufacturer’s instructions. After treatment with
RNase-free DNase (Promega), RNA transcripts were purified with
phenol:chloroform:isoamyl alcohol (25:24:1; Invitrogen). RNA was
denatured at 90 C˚ for 2 min, and incubated for 1 h at room temperature
in the presence of 100 mM KCl, 10 mM MgCl2 and 10 mM Tris-HCl
pH 7.4.
For the pulldown assay, mouse brain and spinal cords were
homogenized using a Teflon homogenizer for 30 s on ice in lysis
buffer (250 mM NaCl, 20 mM Tris-HCl, pH 7.4, 0.5% Nonidet-P40,
0.5 mM DTT, 1 mM PMSF, protease inhibitor cocktail from Sigma-
Aldrich). NSC34 and SH-SY5Y cell lysis was performed in the same
buffer. All animal experiments were performed according to approved
guidelines.
A clear supernatant was obtained by centrifugation of cell and tissue
lysates twice at 20,000 g for 5 min. Protein content was determined using
a Bradford protein assay (Bio-Rad). 1 mg of total protein extract was
diluted in 0.5 ml of lysis buffer with a final NaCl concentration of
150 mM, and then pre-cleared with 60 ml of DynabeadsH M-280
Streptavidin (Invitrogen) for 30 min. The pre-cleared protein extract
was incubated for 1 h with 5 mg of biotinylated (G4C2)31 RNA, and then
with 60 ml of DynabeadsH M-280 Streptavidin for 1 h. After five washes
in lysis buffer, RNA–protein complexes were resuspended in 26
Laemmli sample buffer, boiled for 5 min and subjected to 4–12%
NuPAGE gel elecrophoresis (Invitrogen). A non-biotinylated (G4C2)31
RNA was also pulled-down and analyzed in the same conditions to check
for unspecific binding of proteins. Gels were stained with Coomassie
Blue for the following mass spectrometry analysis or subjected to western
blot analysis.
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Protein identification by mass spectrometry analysis
Bands from gels were processed by tryptic proteolysis, after reduction
and alkylation steps. The peptide mixtures were analyzed by matrix-
assisted laser-desorption ionization–time-of-flight (MALDI-ToF) mass
spectrometry (AutoFlexII, BrukerDaltonics) and the resulting peptide
mass fingerprints were used to identify proteins with the Mascot search
engine (Palermo et al., 2012).
All peptide mixtures were also analyzed by a nano LCLTQ-Orbitrap
mass spectrometer platform. After desalting (Rappsilber et al., 2007) and
resuspension in 0.1% of formic acid, samples were loaded from an
autosampler onto a 10-cm long silica capillary packed with C18 reverse
phase resin, using the Dionex Ultimate 3000 system (LC Packings,
Dionex, Amsterdam, The Netherlands). The elution of peptides was
monitored by a linear ion trap-orbitrap hybrid mass spectrometer (LTQ-
Orbitrap Discovery, Thermo Fisher Scientific) equipped with a
nanoelectrospray ion source (Thermo Fisher Scientific), operating in
the positive ionization mode with a spray voltage of 1.9 kV. In data-
dependent tandem mass spectrometry (MS/MS) scans, the five most
abundant ions were fragmented by collision-induced dissociation (CID)
and analyzed in the linear trap. Data acquisition was controlled by
Xcalibur 2.1. The MS/MS spectra were searched by MaxQuant (v. 1.4.1)
against the mouse UniProtKB FASTA database. The identifications with
only one unique peptide were accepted.
Fluorescence in situ hybridization and
immunofluorescence analysis
Cell cultures were grown on poly-L-lysine-coated glass coverslips,
washed in PBS and fixed with 4% paraformaldehyde in PBS for 10 min.
Cells were then washed twice with 70% ethanol and stored in 70%
ethanol at 4 C˚. Cells were rehydrated with 5 mM MgCl2 in PBS for
30 min and then pre-hybridized in 35% formamide, 10 mM sodium
phosphate pH 7.0, and 26SSC (300 mM NaCl, 30 mM sodium citrate)
for 30 min at room temperature. For the probe hybridization, cells were
incubated with 250 ng/ml of Cy3-labeled (C4G2)4 (Sigma) and/or Cy5-
conjugated oligo(dT) in 30% formamide, 10% dextrane sulphate, 26
SSC, 0.2% BSA, 10 mM sodium phosphate pH 7.0, and 0.5 mg/ml each
of E. coli tRNA and sonicated salmon sperm DNA, at 37 C˚ overnight in a
humidified chamber. After hybridization, cells were washed twice with
35% formamide, 10 mM sodium phosphate, pH 7.0, and 26 SSC for
30 min each at 37 C˚; twice with 26 SSC, 0.1% Triton-X100, 15 min
each at room temperature; and twice with 0.26SSC, 0.1% Triton X-100,
15 min each at room temperature. After washing, coverslips were
mounted on the slides, or processed for immunofluorescence analysis as
follows.
Cells were blocked for 30 min in PBS, 1% BSA and incubated for
1 h at 37 C˚ with primary antibodies (see below) diluted in the same
buffer. Cells were washed in PBS and incubated for 45 min with
fluorophore-conjugated secondary antibodies diluted in PBS, 1% BSA.
After rinsing in PBS, cells were stained with 1 mg/ml DAPI (Sigma)
and examined with a Zeiss LSM 510 Confocal Laser Scanning
Microscope equipped with a 636 objective. Fluorescence images were
processed using ZEN 2009 (Carl Zeiss) and Adobe Photoshop
software.
Protein extraction
After rinsing with ice-cold PBS, cells were lysed in RIPA buffer (50 mM
Tris-HCl, pH 7.4, 1% Triton X-100, 0.25% Na-deoxycholate, 0.1% SDS,
150 mM NaCl, 1 mM EDTA and 5 mM MgCl2) containing a protease
inhibitor cocktail (Sigma). A clear supernatant was obtained by
centrifugation of lysates at 17,000 g for 10 min. Protein content was
determined using Bradford protein assay (Bio-Rad).
For eIF2a phosphorylation measurement, cells were treated with
1 mM sodium orthovanadate for 30 min, then cell lysis was performed in
RIPA buffer containing a protease inhibitor cocktail (Sigma), 1 mM
sodium orthovanadate and 50 mM sodium fluoride.
For translation rate measurement, prior of cell lysis, cell cultures were
treated with 10 mg/ml puromycin for 10 min. Where specified, cells were
previously treated with 1 mM cycloheximide for 10 min.
Nuclear–cytosolic fractionation
After 24 h from transfection, HeLa cells were harvested, washed in ice-
cold PBS and lysed in low-salt buffer (10 mM Hepes, pH 7.4, 42 mM
KCl, 5 mM MgCl2, 0.5% CHAPS, 1 mM DTT, 1 mM PMSF and 1 mg/
ml leupeptin). After 10 min on ice, lysates were centrifuged at 2000 g for
10 min. Supernatants were collected as cytosolic fractions, whereas
pellets were resuspended in high-salt buffer (50 mM Tris-HCl pH 7.4,
400 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.5% Nonidet-P40, 10%
glycerol, 2 mM DTT, 1 mM PMSF, protease inhibitor cocktail from
Sigma-Aldrich). After 30 min on ice, lysates were centrifuged at 20,000
g for 15 min and supernatants were collected as nuclear fractions.
Electrophoresis and western blotting
Protein samples were separated by SDS-PAGE and transferred onto
nitrocellulose membranes (Amersham). Membranes were blocked for 1 h
in Tris-buffered saline solution with 0.1% Tween-20 (TBS-T) containing
5% non-fat dry milk, and then incubated for 2 h at room temperature or
overnight at 4 C˚ with indicated primary antibodies, diluted in TBS-T
containing 2% non-fat dry milk. After rinsing with TBS-T solution,
membranes were incubated for 1 h with the appropriated peroxidase-
conjugated secondary antibody diluted in TBS-T containing 1% non-fat
dry milk, then washed and developed using the ECL chemiluminescence
detection system (Roche). Densitometric analyses were performed using
ImageJ software program (National Institutes of Health).
Antibodies and reagents
The following antibodies were used: anti-hnRNP H, anti-RAX and anti-
laminB goat polyclonal antibodies (Santa Cruz Biotechnology); anti-
hnRNP U (H-94) rabbit polyclonal antibody (Santa Cruz Biotechnology);
anti-ILF2 (G-3), anti-SRSF1 (96), anti-PABP (10E10) mouse monoclonal
antibodies (Santa Cruz Biotechnology); anti-eIF2a (D7D3), anti-
phospho-eIF2a (D9G8) rabbit monoclonal antibodies (Cell Signaling);
anti-eIF2b rabbit polyclonal antibody (GeneTex); anti-ILF3 (EPR3626)
rabbit monoclonal antibody (GeneTex); anti-FUS rabbit polyclonal
antibody (Bethyl Laboratories); anti-TDP43 rabbit polyclonal antibody
(ProteinTech); anti-b-actin mouse monoclonal antibody (Sigma); anti-
Puromycin (12D10) mouse monoclonal antibody (Millipore); anti-
MBNL1 mouse monoclonal (P11) antibody (a kind gift of Annalisa
Botta, Dipartimento di Biomedicina e Prevenzione, University of Rome
Tor Vergata, Italy); anti-hnRNP A2/B1 mouse monoclonal antibody
(GeneTex); anti-FMRP rabbit polyclonal (Ram2) antibody; anti-TIAR
mouse monoclonal antibody (BD Transduction Lab); anti-Pura mouse
monoclonal antibody (Abcam, ab77734); anti-Pura rabbit polyclonal
antibody (Abcam, ab79936). Anti-rabbit, anti-mouse and anti-goat IgG
peroxidase-conjugated secondary antibodies were from Bio Rad; Alexa-
Fluor-conjugated secondary antibodies were from Invitrogen. Anti-
mouse IgG conjugated to Cy3 was from Jackson ImmunoResearch
Laboratories. Poly-U, Poly-G, sodium arsenite, thapsigargin, puromycin
and cyclohexymide were from Sigma. PERK inhibitor GSK2606414 was
from Calbiochem. tRNA was from Roche, and single-stranded (ss)DNA
from Sigma.
Statistical analysis
Statistical analysis was performed with an unpaired two-tailed Student’s
t-test. Values significantly different from the relative control are
indicated with asterisks. P-values of 0.05 or 0.01 were considered
significant.
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